Early last month, Abbott announced that some of its COVID-19 tests produced false positives. According to a recent FierceBiotech article, the FDA has upgraded the test issue to a Class I recall. The issue stemmed from problematic software employed by processing equipment at the lab. The software automates the mixing of chemicals with samples from patients, but in certain instances excess liquid is added causing overflow into adjacent wells in the processing tray. This contamination can lead to negative samples yielding false-positive results.
Faulty Abbott Labs COVID-19 Tests Lead to Recall
Problematic software caused an issue that could affect 10 million COVID-19 tests that have already been distributed.
Oct 20, 2021
Have You Heard About our Podcasts?
Through the Line podcasts explore innovations and information across the packaging and processing landscape. Join us for the latest insights, trends, and strategies shaping packaging and processing today.
Listen Today
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Downloads
